Key statistics
On Friday, Aldeyra Therapeutics Inc (137:STU) closed at 4.67, -27.49% below its 52-week high of 6.44, set on Feb 19, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 4.26 |
|---|---|
| High | 4.71 |
| Low | 4.25 |
| Bid | 4.67 |
| Offer | 4.70 |
| Previous close | 4.30 |
| Average volume | 1.36k |
|---|---|
| Shares outstanding | 60.16m |
| Free float | 53.08m |
| P/E (TTM) | -- |
| Market cap | 306.23m USD |
| EPS (TTM) | -0.7217 USD |
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Press releases
- Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease
- Aldeyra Therapeutics Announces Expansion of RASP Platform to Include Central Nervous System Diseases and Provides Updates on Reproxalap at Research & Development Webcast
- Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
